Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Short term Debt (2020 - 2025)

Historic Short term Debt for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to $12.3 million.

  • Quipt Home Medical's Short term Debt fell 27.53% to $12.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.3 million, marking a year-over-year decrease of 27.53%. This contributed to the annual value of $12.2 million for FY2025, which is 462.36% down from last year.
  • As of Q4 2025, Quipt Home Medical's Short term Debt stood at $12.3 million, which was down 27.53% from $12.2 million recorded in Q3 2025.
  • Quipt Home Medical's Short term Debt's 5-year high stood at $14.1 million during Q3 2023, with a 5-year trough of $281000.0 in Q2 2021.
  • Its 5-year average for Short term Debt is $9.0 million, with a median of $10.9 million in 2023.
  • In the last 5 years, Quipt Home Medical's Short term Debt crashed by 9331.94% in 2021 and then skyrocketed by 449860.63% in 2023.
  • Quipt Home Medical's Short term Debt (Quarter) stood at $6.3 million in 2021, then grew by 1.35% to $6.4 million in 2022, then soared by 104.85% to $13.1 million in 2023, then decreased by 5.62% to $12.4 million in 2024, then fell by 0.28% to $12.3 million in 2025.
  • Its Short term Debt was $12.3 million in Q4 2025, compared to $12.2 million in Q3 2025 and $10.5 million in Q2 2025.